期刊
COLLOIDS AND SURFACES B-BIOINTERFACES
卷 159, 期 -, 页码 327-336出版社
ELSEVIER
DOI: 10.1016/j.colsurfb.2017.07.088
关键词
EPO; NGF; PLGA; Peripheral nerve injury; Sequential release
资金
- Medical Youth Training Program [14QNP101]
The different mechanisms of nerve growth factor (NGF) and erythropoietin (EPO) in promoting repair of peripheral nerve injuries suggest a potential therapeutic application through the synergism of the two. Yet NGF has also been reported to induce early nerve apoptosis after injury. To utilize the potential synergism of NGF and EPO while minimize the possible defect, in this study, we first confirmed the time dependency of NGF caused nerve apoptosis, and then established a sequential and sustained delivery system for NGF and EPO with poly(lactide-co-glycolide) (PLGA), which has been approved by the US FDA for human use because of its injectable, biocompatible, and biodegradable properties. EPO was encapsulated in PLGA-microspheres (MS) for sustained releasing, while NGF was encapsulated in BSA incorporated PLGA (B-PLGA) MS to postpone its release. In rat model of sciatic nerve injury, co-deliveryof EPO/PLGA-MS and NGF/B-PLGA-MS resulted in significant nerve recovery. Hopefully, this sequential delivery system could provide a new therapeutic strategy for peripheral never injury. (C) 2017 Published by Elsevier B.V.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据